MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.aed.2026.04.008

Медицинская библиотека · AACE endocrinology and diabetes · 2026

Romosozumab Treatment After Parathyroidectomy for Primary Hyperparathyroidism-Complicated Osteoporosis: A Two-Case Report.

Takebe Saya, Seki Yasufumi, Morimoto Satoshi, Watanabe Daisuke, Ichihara Atsuhiro

Клинический случайСтатьяПеревод в очереди

Аннотация

BACKGROUND/

OBJECTIVE

Parathyroidectomy increases bone mineral density (BMD) by 3% to 4% in patients with primary hyperparathyroidism (PHPT); however, limited studies have demonstrated the effect of postoperative medical therapy, particularly with bisphosphonate and denosumab, on BMD. Herein, we report 2 cases of PHPT in which romosozumab, an antisclerostin antibody, increased BMD after parathyroidectomy.

CASE REPORT: Case 1. A 67-year-old woman was diagnosed with PHPT and advanced osteoporosis, with T-scores of -4.0 and -5.4 in the lumbar spine (LS) and distal radius (DR), respectively. After parathyroidectomy and 5-year treatment with eldecalcitol and raloxifene, T-scores were -3.3 and -5.6 in the LS and DR, respectively. Thereafter, 12-month romosozumab therapy with eldecalcitol increased BMD by 25.2% (0.717 to 0.898 g/cm2) and 4.0% (0.351 to 0.365 g/cm2) in the LS and DR, respectively. Case 2. A 64-year-old woman was diagnosed with PHPT and advanced osteoporosis, with T-scores of -4.1 and -4.9 in the LS and DR, respectively. Four months after parathyroidectomy, 12-month therapy with romosozumab and eldecalcitol increased BMD by 30.1% (0.602 to 0.783 g/cm2) and 4.3% (0.532 to 0.555 g/cm2) in the LS and total hip, respectively.

DISCUSSION: We present the first reported cases of PHPT-complicated osteoporosis in which BMD improved after romosozumab treatment markedly in the LS by 25% to 30%. These cases suggest that postoperative romosozumab therapy may be a potential therapeutic option in patients with PHPT and osteoporosis.

CONCLUSION

Romosozumab may be a promising postoperative therapy for patients with PHPT and osteoporosis.

Для цитирования: Takebe Saya, Seki Yasufumi, Morimoto Satoshi, Watanabe Daisuke, Ichihara Atsuhiro. Romosozumab Treatment After Parathyroidectomy for Primary Hyperparathyroidism-Complicated Osteoporosis: A Two-Case Report.. AACE endocrinology and diabetes. 2026. DOI: 10.1016/j.aed.2026.04.008.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.